Government investment will accelerate clinical development and strengthen Aspect’s advanced biomanufacturing capabilities for its bioengineered cellular medicinesVANCOUVER, British Columbia--(BUSINESS ...

SV Health Investors (“SVHI”), a healthcare and life sciences focused private investment firm, announced today the acquisition ...

Gedeon Richter's Side-by-Side Conference on Advancing Women's Health brought together Healthcare practitioners from 40 ...

Further Diversifies Revenue Mix With Leading Position in Industrial, Pharmaceutical End MarketsExpands Mechanical Services ...

Biogen will acquire Apellis for 5.6 billion dollars, adding two approved therapies and boosting growth in immunology and ...

Agentic AI in Healthcare Market OverviewThe global agentic AI in healthcare market is poised for exponential growth, with an ...

Care Market OverviewThe global digital musculoskeletal (MSK) care market is poised for robust expansion, with an anticipated ...

Regulatory News:Celyad Oncology (Euronext: CYAD) (the “Company”), today announces its financial results for the fiscal year ...

New market-intelligence report finds post-acute providers are prioritizing practical technologies and managed services that ...

Affordable, cloud-based SaaS solution automates E2B (R2) to E2B (R3) conversion for small and mid-size pharma ...

Taiwan manufacturing strategy, with 2027 operations in sightBURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical company headquartered in Taiwan, ...

Tenpoint Therapeutics, a leading ophthalmic manufacturer, and PHIL Inc., an all-in-one digital hub and Direct-to-Patient ...